Pertti Jaakko Neuvonen - Nanotechnology

Author Information

Pertti Jaakko Neuvonen is a prominent researcher in the field of Nanotechnology, with a significant focus on pharmacokinetics and drug interactions. While his specific affiliation is not provided, his email is associated with PubMed, indicating his active engagement with the research community.

Research Contributions

Throughout his career, Pertti Jaakko Neuvonen has made substantial contributions to the understanding of drug interactions and pharmacokinetics. His recent research includes studying the impact of antimicrobial use on the saliva microbiome and its implications on weight status during adolescence. Additionally, his work extensively covers the pharmacokinetics of various drugs and their interactions, such as the effects of clopidogrel and gemfibrozil on desloratadine exposure and the impact of CYP3A4*22 on ticagrelor elimination. These studies are crucial for developing safer and more effective drug therapies.

Aliases

Pertti Jaakko Neuvonen is known by several aliases, which include Pertti Neuvonen, P. J. Neuvonen, P. Neuvonen, Pertti J. Neuvonen, and P.j. Neuvonen, among others. These variations in his name may appear in different publications and databases.

Publication and Citation Metrics

Metric	Value
Total Citations	31,584
h-index	94
Total Papers	574

Publications:

Early life antimicrobial use and the effects on the saliva microbiome

DOI: 10.21203/rs.3.rs-106647/v1

Year: 2020

Antimicrobial drug use in the first decade of life influences saliva microbiota diversity and composition

DOI: 10.1186/s40168-020-00893-y

Year: 2020

Lifetime antimicrobial use is associated with weight status in early adolescence—A register‐based cohort study

DOI: 10.1111/ijpo.12727

Year: 2020

Response to “Interaction of Dasabuvir With Clopidogrel: Did Predictions by Physiologically Based Pharmacokinetics Modeling Pass the Test?”

DOI: 10.1002/cpt.1195

Year: 2019

A Physiologically Based Pharmacokinetic Model of Voriconazole Integrating Time-Dependent Inhibition of CYP3A4, Genetic Polymorphisms of CYP2C19 and Predictions of Drug–Drug Interactions

DOI: 10.1007/s40262-019-00856-z

Year: 2019

Withdrawal from long‐term use of zopiclone, zolpidem and temazepam may improve perceived sleep and quality of life in older adults with primary insomnia

DOI: 10.1111/bcpt.13144

Year: 2019

Itraconazole Increases Ibrutinib Exposure 10‐Fold and Reduces Interindividual Variation—A Potentially Beneficial Drug‐Drug Interaction

DOI: 10.1111/cts.12716

Year: 2019

Clopidogrel and Gemfibrozil Strongly Inhibit the CYP2C8-Dependent Formation of 3-Hydroxydesloratadine and Increase Desloratadine Exposure In Humans

DOI: 10.1124/dmd.118.084665

Year: 2019

CYP3A4*22 Impairs the Elimination of Ticagrelor, But Has No Significant Effect on the Bioactivation of Clopidogrel or Prasugrel

DOI: 10.1002/cpt.1177

Year: 2019

Clopidogrel Increases Dasabuvir Exposure With or Without Ritonavir, and Ritonavir Inhibits the Bioactivation of Clopidogrel

DOI: 10.1002/cpt.1099

Year: 2019

Why Is Industry Collaboration Important?

What is Spectroscopy in Nanotechnology?

Why are Networks Important in Nanotechnology?

What are the Challenges in Nanomaterial Development?

What Methods are Used to Assess Nanotoxicity?

Why is Template Assisted Synthesis Important?

How Do Field Emission Sources Work?

What Will You Study?

What is Reduced Efficiency in Nanotechnology?

How is toxicity testing performed on nanomaterials?

Partnered Content Networks

Relevant Topics